You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
  • Plasma Cell Leukemia
  • +2 more
  • Biospecimen Collection
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-10-18
Oct 18, 2021
A
Available
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • (no location specified)
2021-05-24
May 24, 2021
U
Recruiting
  • Multiple Myeloma
  • +8 more
    • Chapel Hill, North Carolina
      North Carolina Cancer Hospital
    2021-11-30
    Nov 30, 2021
    S
    Completed
    • Myelodysplastic Syndrome
    • +13 more
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    2021-09-24
    Sep 24, 2021
    M
    Recruiting
    • Acute Myelogenous Leukemia
    • +17 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    2021-05-21
    May 21, 2021
    M
    Active, not recruiting
    • Plasma Cell Leukemia
    • +2 more
    • Rochester, Minnesota
    • +1 more
    2021-04-06
    Apr 6, 2021
    M
    Recruiting
    • Acute Myeloid Leukemia (AML)
    • +17 more
    • Minneapolis, Minnesota
      University of Minnesota Masonic Cancer Center
    2021-10-27
    Oct 27, 2021
    M
    Recruiting
    • Acute Leukemia
    • +27 more
    • HSCT with TBI Regimen
    • HSCT with Non-TBI Regimen
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    2021-05-21
    May 21, 2021
    M
    Recruiting
    • Acute Leukemia
    • +24 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    2021-11-04
    Nov 4, 2021
    R
    Recruiting
    • Partial Response of Multiple Myeloma or Plasma Cell Leukemia
    • Plasma Cell Myeloma
    • Incomplete Freund's Adjuvant
    • +4 more
    • Buffalo, New York
    • +1 more
    2021-06-21
    Jun 21, 2021
    P
    Completed
    • Multiple Myeloma
    • Plasma Cell Leukemia
    • ARRY-520, KSP(Eg5) inhibitor; intravenous
    • +2 more
    • Atlanta, Georgia
    • +4 more
    2020-10-08
    Oct 8, 2020
    M
    Active, not recruiting
    • Plasma Cell Leukemia
    • Plasma Cell Myeloma
    • Autologous Hematopoietic Stem Cell Transplantation
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    2021-11-09
    Nov 9, 2021
    M
    Active, not recruiting
    • Plasma Cell Leukemia
    • +3 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    2021-11-18
    Nov 18, 2021
    C
    Active, not recruiting
    • Autologous Hematopoietic Stem Cell Transplant Recipient
    • +4 more
    • Duarte, California
      City of Hope
    2021-03-08
    Mar 8, 2021
    M
    Not yet recruiting
    • Leukemia, Myeloid, Acute
    • +5 more
    • Melbourne, Victoria, Australia
      Melbourne Health
    2021-09-14
    Sep 14, 2021
    V
    Active, not recruiting
    • Hodgkin's Lymphoma
    • +17 more
    • mycophenolate mofetil
    • +2 more
    • Richmond, Virginia
      Virginia Commonwealth University/Massey Cancer Center
    2021-12-21
    Dec 21, 2021
    M
    Completed
    • Plasma Cell Leukemia
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    2019-07-12
    Jul 12, 2019
    M
    Completed
    • Leukemia
    • +2 more
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    2020-11-12
    Nov 12, 2020
    A
    Completed
    • Multiple Myeloma, Plasma Cell Leukemia
    • ARRY-520, KSP(Eg5) inhibitor; intravenous
    • +3 more
    • Huntsville, Alabama
    • +12 more
    2020-09-28
    Sep 28, 2020
    C
    Completed
    • Anemia
    • +12 more
    • Laboratory Biomarker Analysis
    • +5 more
    • Duarte, California
      City of Hope Medical Center
    2021-02-10
    Feb 10, 2021
    M
    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • +15 more
    • Houston, Texas
      M D Anderson Cancer Center
    2021-06-24
    Jun 24, 2021
    F
    Recruiting
    • Acute Biphenotypic Leukemia
    • +29 more
    • Seattle, Washington
    • +1 more
    2021-07-07
    Jul 7, 2021
    U
    Recruiting
    • Recurrent Chronic Lymphocytic Leukemia
    • +17 more
    • Nivolumab
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    2021-07-14
    Jul 14, 2021
    O
    Completed
    • Plasma Cell Leukemia
    • Recurrent Plasma Cell Myeloma
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +9 more
    • Durham, North Carolina
    • +1 more
    2020-11-19
    Nov 19, 2020